Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart pain monitor could cut opioid use in robotic surgery

NCT ID NCT05662371

Recruiting now Symptom relief Sponsor: University of Southern Denmark Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device called the Nociception Level (NOL) monitor, which tracks pain signals during surgery. The goal is to help doctors give the right amount of pain medicine, avoiding too much or too little. The trial will include 60 adults having robotic colorectal surgery and will measure painkiller use, recovery quality, and hospital stay length.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Nociception Level monitor (NOL) device
What this could lead to
If successful, this device could help doctors give just the right amount of pain medicine during surgery, reducing side effects and speeding up recovery.
What could go wrong
This is a small, early-stage study with only 60 participants. The device may not improve outcomes significantly, and results may not apply to other types of surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE, UNSPECIFIED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID USE, UNSPECIFIED PAIN, POSTOPERATIVE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Anaesthesiology and Intensive Care Research Unit

    RECRUITING

    Aabenraa, Denmark

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.